EPSTEIN ROBERT S 4
4 · VERACYTE, INC. · Filed Oct 3, 2025
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
EPSTEIN ROBERT S
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2025-10-01−10,000→ 0 totalExercise: $7.94From: 2018-06-07Exp: 2027-06-07→ Common Stock (10,000 underlying) - Sale
Common Stock
2025-10-01$35.08/sh−21,473$753,204→ 62,446 total - Exercise/Conversion
Common Stock
2025-10-01$7.94/sh+10,000$79,400→ 83,919 total
Footnotes (2)
- [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 5, 2025.
- [F2]Represents weighted average sales price. Sale prices for the transactions range from $35.00 to $35.30. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.